168 related articles for article (PubMed ID: 19194082)
1. Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog.
Teshima T; Hara Y; Shigihara K; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
J Vet Med Sci; 2009 Jan; 71(1):93-8. PubMed ID: 19194082
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma.
Sato A; Ochi H; Harada Y; Yogo T; Kanno N; Hara Y
Domest Anim Endocrinol; 2017 Jan; 58():126-133. PubMed ID: 26542941
[TBL] [Abstract][Full Text] [Related]
3. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
5. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
Saeger W
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
[No Abstract] [Full Text] [Related]
6. Pituitary tumour types in dogs and cats.
Sanders K; Galac S; Meij BP
Vet J; 2021 Apr; 270():105623. PubMed ID: 33641809
[TBL] [Abstract][Full Text] [Related]
7. Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease.
Granger N; de Fornel P; Devauchelle P; Segond S; Delisle F; Rosenberg D
J Vet Intern Med; 2005; 19(1):23-8. PubMed ID: 15715043
[TBL] [Abstract][Full Text] [Related]
8. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transsphenoidal surgery on endocrinological status and serum chemistry parameters in dogs with Cushing's disease.
Hara Y; Teshima T; Taoda T; Ishino H; Nezu Y; Harada Y; Yogo T; Masuda H; Teramoto A; Tagawa M
J Vet Med Sci; 2010 Apr; 72(4):397-404. PubMed ID: 19996557
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease.
de Bruin C; Hanson JM; Meij BP; Kooistra HS; Waaijers AM; Uitterlinden P; Lamberts SW; Hofland LJ
Endocrinology; 2008 Sep; 149(9):4357-66. PubMed ID: 18483151
[TBL] [Abstract][Full Text] [Related]
11. Type II muscle fibers atrophy associated with silent corticotroph adenoma in a dog.
Trapani F; Del Basso De Caro ML; Insabato L; Papparella S; Paciello O
Folia Histochem Cytobiol; 2010 Sep; 48(3):403-6. PubMed ID: 21071346
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Evaluation of Canine Pituitary Adenomas Obtained by Transsphenoidal Hypophysectomy.
Miller MA; Owen TJ; Bruyette DS; Scott-Moncrieff JC; Ramos-Vara JA; Weng HY; Chen AV; Martin LG; DuSold DM
Vet Pathol; 2018 Nov; 55(6):889-895. PubMed ID: 29925292
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.
Haap M; Gallwitz B; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700
[TBL] [Abstract][Full Text] [Related]
14. Rare case of Cushing's disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk.
Mendola M; Dolci A; Piscopello L; Tomei G; Bauer D; Corbetta S; Ambrosi B
Hormones (Athens); 2014; 13(4):574-8. PubMed ID: 25402386
[TBL] [Abstract][Full Text] [Related]
15. Gamma knife radiosurgery in patients with Cushing's disease: Comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma.
Kara M; Güdük M; Samanci Y; Yilmaz M; Şengöz M; Peker S
Clin Neurol Neurosurg; 2020 Oct; 197():106151. PubMed ID: 32882541
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.
van Rijn SJ; Hanson JM; Zierikzee D; Kooistra HS; Penning LC; Tryfonidou MA; Meij BP
J Vet Intern Med; 2015; 29(3):869-76. PubMed ID: 25959680
[TBL] [Abstract][Full Text] [Related]
17. Cushing's disease complicated with thrombosis in a dog.
Teshima T; Hara Y; Taoda T; Koyama H; Takahashi K; Nezu Y; Harada Y; Yogo T; Nishida K; Osamura RY; Teramoto A; Tagawa M
J Vet Med Sci; 2008 May; 70(5):487-91. PubMed ID: 18525172
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of pituicytoma and corticotroph adenoma in a patient with Cushing's disease.
Wee Z; Tang PY; Lai SH; Ang BT; Chandran SR
Pathology; 2023 Apr; 55(3):432-435. PubMed ID: 36351865
[No Abstract] [Full Text] [Related]
19. Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs.
Sato A; Hara Y
Res Vet Sci; 2018 Aug; 119():61-66. PubMed ID: 29864631
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
Castillo V; Giacomini D; Páez-Pereda M; Stalla J; Labeur M; Theodoropoulou M; Holsboer F; Grossman AB; Stalla GK; Arzt E
Endocrinology; 2006 Sep; 147(9):4438-44. PubMed ID: 16740975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
